Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

DGAP-News: Burcon NutraScience Corp.: Burcon to Participate at the 32nd Annual ROTH Conference on March 15-17, 2020
DGAP-News: Burcon NutraScience Corp.: Burcon to Participate at the 32nd Annual ROTH Conference on March 15-17, 2020
DGAP-News: Burcon NutraScience Corp.: Burcon to Participate at the 32nd Annual ROTH Conference on March 15-17, 2020
eqs_en 
0 11.03.20
DGAP-News: ADO Properties S.A.: ADLER shareholders support the business combination with ADO Properties
DGAP-News: ADO Properties S.A.: ADLER shareholders support the business combination with ADO Properties
DGAP-News: ADO Properties S.A.: ADLER shareholders support the business combination with ADO Properties
eqs_en 
0 11.03.20
EQS Group AG: Companies increasingly opting for online broadcasts due to coronavirus
EQS Group AG: Companies increasingly opting for online broadcasts due to coronavirus
EQS Group AG: Companies increasingly opting for online broadcasts due to coronavirus
eqs_en 
0 11.03.20
DGAP-News: LION E-Mobility AG: Invitation to Investor Conference Call - Lion Sogefi Agreement
DGAP-News: LION E-Mobility AG: Invitation to Investor Conference Call - Lion Sogefi Agreement
DGAP-News: LION E-Mobility AG: Invitation to Investor Conference Call - Lion Sogefi Agreement
eqs_en 
0 11.03.20
DGAP-Adhoc: PUMA SE: PUMA no longer expects a short-term normalization of the COVID-19 situation despite first encouraging signs coming out of China
DGAP-Adhoc: PUMA SE: PUMA no longer expects a short-term normalization of the COVID-19 situation despite first encouraging signs coming out of China
DGAP-Adhoc: PUMA SE: PUMA no longer expects a short-term normalization of the COVID-19 situation despite first encouraging signs coming out of China
eqs_en 
0 11.03.20
DGAP-Adhoc: Xlife Sciences AG: Active pharmaceutical ingredient for pneumonia caused by COVID-19 (coronavirus)
DGAP-Adhoc: Xlife Sciences AG: Active pharmaceutical ingredient for pneumonia caused by COVID-19 (coronavirus)
DGAP-Adhoc: Xlife Sciences AG: Active pharmaceutical ingredient for pneumonia caused by COVID-19 (coronavirus)
eqs_en 
0 11.03.20
Trading statement
Trading statement
Trading statement
eqs_en 
0 11.03.20
TCS Group Holding PLC reports record net income in 4Q and FY 2019, announces 1st 2020 interim dividend
TCS Group Holding PLC reports record net income in 4Q and FY 2019, announces 1st 2020 interim dividend
TCS Group Holding PLC reports record net income in 4Q and FY 2019, announces 1st 2020 interim dividend
eqs_en 
0 11.03.20
DGAP-News: 11880 Solutions AG cracks important customer hurdle: 40,000 small and medium-sized companies trust in digital marketing
DGAP-News: 11880 Solutions AG cracks important customer hurdle: 40,000 small and medium-sized companies trust in digital marketing
DGAP-News: 11880 Solutions AG cracks important customer hurdle: 40,000 small and medium-sized companies trust in digital marketing
eqs_en 
0 11.03.20
DGAP-News: Hannover Re delivers double-digit earnings and premium growth and increases dividend : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23716/345px-HannoverRe.svg.png
DGAP-News: Hannover Re delivers double-digit earnings and premium growth and increases dividend
DGAP-News: Hannover Re delivers double-digit earnings and premium growth and increases dividend
eqs_en 
0 11.03.20
DGAP-News: Newron updates on STARS study FDA interaction: https://mms.businesswire.com/media/20200216005057/en/682845/5/logo_color_high_res.jpg
DGAP-News: Newron updates on STARS study FDA interaction
DGAP-News: Newron updates on STARS study FDA interaction
eqs_en 
0 11.03.20
EQS-Adhoc: Von Roll Holding AG: Von Roll returns to profitability despite difficult markets
EQS-Adhoc: Von Roll Holding AG: Von Roll returns to profitability despite difficult markets
EQS-Adhoc: Von Roll Holding AG: Von Roll returns to profitability despite difficult markets
eqs_en 
0 11.03.20
DGAP-News: Knorr-Bremse AG presents strong preliminary FY19 results - Aims for climate neutrality in 2021
DGAP-News: Knorr-Bremse AG presents strong preliminary FY19 results - Aims for climate neutrality in 2021
DGAP-News: Knorr-Bremse AG presents strong preliminary FY19 results - Aims for climate neutrality in 2021
eqs_en 
0 11.03.20
DGAP-News: Ferratum Oyj: Fitch Affirms Ferratum at 'BB-'; Outlook Stable
DGAP-News: Ferratum Oyj: Fitch Affirms Ferratum at 'BB-'; Outlook Stable
DGAP-News: Ferratum Oyj: Fitch Affirms Ferratum at 'BB-'; Outlook Stable
eqs_en 
0 10.03.20
Kaufman & Broad SA: AMENDMENT OF THE MANDATE FOR THE SHARE BUYBACK PROGRAM
Kaufman & Broad SA: AMENDMENT OF THE MANDATE FOR THE SHARE BUYBACK PROGRAM
Kaufman & Broad SA: AMENDMENT OF THE MANDATE FOR THE SHARE BUYBACK PROGRAM
eqs_en 
0 10.03.20
DGAP-News: ENCAVIS AG: Scope Ratings confirmed investment grade issuer rating BBB- with stable outlook
DGAP-News: ENCAVIS AG: Scope Ratings confirmed investment grade issuer rating BBB- with stable outlook
DGAP-News: ENCAVIS AG: Scope Ratings confirmed investment grade issuer rating BBB- with stable outlook
eqs_en 
0 10.03.20
DGAP-News: Biofrontera AG: European Commission approves use of Ameluz(R) for the treatment of actinic keratosis on extremities and trunk/neck
DGAP-News: Biofrontera AG: European Commission approves use of Ameluz(R) for the treatment of actinic keratosis on extremities and trunk/neck
DGAP-News: Biofrontera AG: European Commission approves use of Ameluz(R) for the treatment of actinic keratosis on extremities and trunk/neck
eqs_en 
0 10.03.20
DGAP-Adhoc: publity AG: publity: Forecast clearly exceeded - consolidated net income 2019 according to preliminary numbers of around 62 million EUR more than 150 percent above previous year
DGAP-Adhoc: publity AG: publity: Forecast clearly exceeded - consolidated net income 2019 according to preliminary numbers of around 62 million EUR more than 150 percent above previous year
DGAP-Adhoc: publity AG: publity: Forecast clearly exceeded - consolidated net income 2019 according to preliminary numbers of around 62 million EUR more than 150 percent above previous year
eqs_en 
0 10.03.20
DGAP-Adhoc: MAX Automation SE: Andreas Krause to resign as member of the Administrative Board, Managing Director (CFO) and Chairman of the Management Board by mid of the year
DGAP-Adhoc: MAX Automation SE: Andreas Krause to resign as member of the Administrative Board, Managing Director (CFO) and Chairman of the Management Board by mid of the year
DGAP-Adhoc: MAX Automation SE: Andreas Krause to resign as member of the Administrative Board, Managing Director (CFO) and Chairman of the Management Board by mid of the year
eqs_en 
0 10.03.20
Daily Mail and General Trust plc: Director/PDMR Shareholding
Daily Mail and General Trust plc: Director/PDMR Shareholding
Daily Mail and General Trust plc: Director/PDMR Shareholding
eqs_en 
0 10.03.20
Fuller, Smith & Turner PLC: Transaction in Own Shares
Fuller, Smith & Turner PLC: Transaction in Own Shares
Fuller, Smith & Turner PLC: Transaction in Own Shares
eqs_en 
0 10.03.20
Form 8.3 - The Vanguard Group, Inc.: Aon plc
Form 8.3 - The Vanguard Group, Inc.: Aon plc
Form 8.3 - The Vanguard Group, Inc.: Aon plc
eqs_en 
0 10.03.20
Form 8.3 - The Vanguard Group, Inc.: Willis Towers Watson plc
Form 8.3 - The Vanguard Group, Inc.: Willis Towers Watson plc
Form 8.3 - The Vanguard Group, Inc.: Willis Towers Watson plc
eqs_en 
0 10.03.20
DGAP-News: Deutsche Post AG: Form notification of share repurchase programme: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23602/Logo_Deutsche_Post_DHL.svg.png
DGAP-News: Deutsche Post AG: Form notification of share repurchase programme
DGAP-News: Deutsche Post AG: Form notification of share repurchase programme
eqs_en 
0 10.03.20
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
eqs_en 
0 10.03.20